NEW YORK, March 13, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LXRX, SAVA, CLSD, LTRN, and ATAI.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  1. LXRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LXRX&prnumber=202403132
  2. SAVA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SAVA&prnumber=202403132
  3. CLSD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CLSD&prnumber=202403132
  4. LTRN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LTRN&prnumber=202403132
  5. ATAI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATAI&prnumber=202403132

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-lexicon-pharmaceuticals-cassava-sciences-clearside-biomedical-lantern-pharma-or-atai-life-sciences-302088039.html

SOURCE InvestorsObserver